# A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL

> **NCT00799136** · PHASE2 · COMPLETED · sponsor: **Ontario Clinical Oncology Group (OCOG)** · enrollment: 6 (actual)

## Conditions studied

- Lymphoma, AIDS Related
- HIV Infections

## Interventions

- **DRUG:** R-EPOCH and cART

## Key facts

- **NCT ID:** NCT00799136
- **Lead sponsor:** Ontario Clinical Oncology Group (OCOG)
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2012-12
- **Final completion:** 2013-09
- **Target enrollment:** 6 (ACTUAL)
- **Last updated:** 2013-09-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00799136

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00799136, "A Feasibility Study of Co-administering Combination Antiretroviral Therapy (cART) and R-EPOCH Chemotherapy for the Management of ARL". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00799136. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*